Some studies have also reported alterations in IGF-1 levels post-TBI, with potential correlations between IGF-1 concentrations and recovery outcomes.10–12 However, these studies often suffer from small sample sizes and methodological limitations, leaving significant gaps in the current understanding of IGF-1 as a prognostic marker for mTBI. The gene discussed is IGF1; the disease is concussion.